Virtual Incision Corporation, a medical device company pioneering a first-of-its-kind miniaturized surgical platform, has announced it has received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) for the company’s MIRA (“miniaturized in vivo robotic assistant”) Platform.
READ MORE




